IBBJ

Defiance NASDAQ Junior Biotechnology ETF
*Unless otherwise stated, data provided by FactSet.

IBBJ Fund Description

IBBJ tracks a market-cap-weighted index of small-cap biotech and pharmaceutical companies listed on the NASDAQ.

IBBJ Factset Analytics Insight

The security is being delisted. The last day of trading on an exchange is December 2, 2021. IBBJ covers companies that are focused on various areas within the biotech or pharmaceuticals space. Included companies are those involved in genomics, DNA technology, genetic engineering, and molecular biology, as well as pharmaceutical manufacturers of prescription or over-the counter drugs. Its emphasis on pharmaceuticals makes IBBJ different from some peer funds and its segment benchmark. The underlying index concentrates its exposure to approximately 200 small-cap stocks that are exclusively listed on the NASDAQ Stock Market. Stocks selected must meet certain size and liquidity requirements. The index is market-cap weighted with 8% single security cap for five securities, and the excess is allocated proportionally across the rest. Index’s rebalance and reconstitution occurs semi-annually.

IBBJ MSCI ESG Analytics Insight

Defiance NASDAQ Junior Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 4.83 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Defiance NASDAQ Junior Biotechnology ETF ranks in the 24th percentile within its peer group and in the 26th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IBBJ MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 11/29/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IBBJ 4.58% 0.27% -13.07% -0.47% -- -- --
IBBJ (NAV) 4.58% -2.44% -13.06% -3.22% -- -- --
NASDAQ Junior Biotechnology Index -- -- -- -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IBBJ Summary Data

Defiance ETFs
Defiance
08/03/20
Open-Ended Fund
0.45%
$7.48M
$82.65K
0.30%

IBBJ Portfolio Data

$3.90B
-13.41
5.41
1.00%
N/A
231

IBBJ Index Data

NASDAQ Junior Biotechnology Index
Market Cap
NASDAQ - Listed
N/A

IBBJ Portfolio Management

0.45%
--
--
--

IBBJ Tax Exposures

20.00% / 39.60%
1.20%
Qualified dividends
No

IBBJ Fund Structure

Open-Ended Fund
No
N/A
-- / --
N/A
N/A
Closing
Daily

IBBJ Factset Analytics Block Liquidity

As of 11/30/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBBJ. IBBJ is rated a N/A out of 5.

IBBJ Tradability

2,827
$82.65K
2,126
$62.90K
0.30%
$0.09
0.04%
2.02% / -1.33%
None
98.00%
50,000
0.04
0.03%
--
2
$29.93
N/A

IBBJ Sector/Industry Breakdown


IBBJ
Segment Benchmark
47.55%
--
29.04%
--
7.91%
--
6.53%
--
1.87%
--
1.39%
--
1.02%
--
0.81%
--
0.78%
--
0.37%
--

IBBJ Top 10 Holdings

0.09%
-0.03%
100.00%

IBBJ Countries


IBBJ
Segment Benchmark
92.77%
--
3.30%
--
0.96%
--
0.77%
--
0.68%
--
0.59%
--
0.51%
--
0.22%
--
0.12%
--
0.08%
--

IBBJ Regions


IBBJ
Segment Benchmark
92.77%
--
4.26%
--
2.75%
--
0.22%
--

IBBJ Economic Development


IBBJ
Segment Benchmark
99.04%
--
0.96%
--

IBBJ Performance Statistics

--
--
--
--
0.00%
N/A

IBBJ MSCI ESG Ratings

4.83 / 10
25.90
23.78
--
--
26.45

IBBJ Benchmark Comparison Holdings

231
--
--
0.00%

IBBJ Benchmark Comparison Summary


IBBJ
Segment Benchmark
231
--
$3.90B
--
-13.41
--
5.41
--
0.03%
--
Low
High

IBBJ Benchmark Comparison Market Cap Size


IBBJ
Segment Benchmark
3.84%
--
51.41%
--
36.22%
--
8.45%
--